REDUCTION OF THE MORTALITY-RATE BY IMIDAPRIL IN A SMALL CORONARY-ARTERY DISEASE-MODEL, (NZW X BXSB)F1 MALE-MICE

被引:8
作者
OGIKU, N [1 ]
SUMIKAWA, H [1 ]
NISHIMURA, T [1 ]
NARITA, H [1 ]
ISHIDA, R [1 ]
机构
[1] TANABE SEIYAKU CO LTD,PHARMACOL RES LAB,TODA,SAITAMA 335,JAPAN
关键词
IMIDAPRIL; (NZW X BXSB)F1 MALE MICE; MYOCARDIAL INFARCTION;
D O I
10.1254/jjp.64.129
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
For this study, we used (NZW x BXSB)F1 male mice as a model of myocardial infarction. The animals were kept on water containing imidapril or enalapril at 60 mg/kg/day from 10 to 27 weeks of age. Imidapril and enalapril significantly reduced the blood pressure. Imidapril reduced the mortality rate more significantly than enalapril did. In the second experiment where imidapril, enalapril and captopril were administered to the mice at 5 mg/kg/day, p.o., both imidapril and captopril significantly reduced the mortality, but enalapril did not. Blood pressure was slightly reduced by these ACE inhibitors. These data suggest that imidapril and captopril are efficacious for the treatment of myocardial infarction and blood pressure reduction hardly contributes to its mechanism of action.
引用
收藏
页码:129 / 133
页数:5
相关论文
共 15 条
[1]  
DECK CC, 1992, J PHARMACOL EXP THER, V263, P1424
[2]   TISSUE RENIN-ANGIOTENSIN SYSTEM IN MYOCARDIAL HYPERTROPHY AND FAILURE [J].
DZAU, VJ .
ARCHIVES OF INTERNAL MEDICINE, 1993, 153 (08) :937-942
[3]   THE ROLE OF HYPERTENSION IN THE VASCULAR-DISEASE AND MYOCARDIAL INFARCTS ASSOCIATED WITH MURINE SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
HANG, L ;
STEPHENSLARSON, P ;
HENRY, JP ;
DIXON, FJ .
ARTHRITIS AND RHEUMATISM, 1983, 26 (11) :1340-1345
[4]   (NZW X BXSB)F1 HYBRID - A MODEL OF ACUTE LUPUS AND CORONARY VASCULAR-DISEASE WITH MYOCARDIAL-INFARCTION [J].
HANG, LM ;
IZUI, S ;
DIXON, FJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1981, 154 (01) :216-221
[5]   O-25 EFFECT OF CARDIOPROTECTIVE DRUGS ON CARDIOMYOPATHIC HAMSTER J-2-N [J].
KATO, M ;
YANG, J ;
TAKEDA, N ;
NAGANO, M .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1992, 24 :S49-S49
[6]   PHARMACOLOGICAL STUDIES ON (4S)-1-METHYL-3-((2S)-2-[N-((1S)-1-ETHOXYCARBONYL-3-PHENYLPROPYL)AMINO] PROPIONYL)-2-OXO-IMIDAZOLIDINE-4-CARBOXYLIC ACID HYDROCHLORIDE (TA-6366), A NEW ACE INHIBITOR .1. ACE INHIBITORY AND ANTIHYPERTENSIVE ACTIVITIES [J].
KUBO, M ;
KATO, J ;
OCHIAI, T ;
ISHIDA, R .
JAPANESE JOURNAL OF PHARMACOLOGY, 1990, 53 (02) :201-210
[7]  
KUBO M, 1992, PHARMACOMETRICS, V43, P173
[8]   SELECTIVE ACTIVATION OF CARDIAC ANGIOTENSINOGEN GENE-EXPRESSION IN POSTINFARCTION VENTRICULAR REMODELING IN THE RAT [J].
LINDPAINTNER, K ;
LU, WY ;
NIEDERMAJER, N ;
SCHIEFFER, B ;
JUST, H ;
GANTEN, D ;
DREXLER, H .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1993, 25 (02) :133-143
[9]  
POULTER NR, 1990, J HUM HYPERTENS, V4, P3
[10]   IMPORTANCE OF RAA SYSTEM AND THE TREATMENT OF PATIENTS WITH ACE INHIBITION AFTER MYOCARDIAL-INFARCTION [J].
RAY, SG ;
MCALPINE, HM ;
MORTON, JJ ;
LECKIE, B ;
DARGIE, HJ .
ANGIOLOGY, 1991, 42 (04) :268-272